Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Bell

Showing results (61-70 of 105) with videos related to

Pageof 11
Sort By:
Human Gene Therapy|April 25, 2019
Safe and Sustained Expression of Human Iduronidase After Intrathecal Administration of Adeno-Associated Virus Serotype 9 in Infant Rhesus MonkeysJuliette Hordeaux, Christian Hinderer, Elizabeth L Buza, et al.
Human Gene Therapy|August 12, 2016
Delivery of an Adeno-Associated Virus Vector into Cerebrospinal Fluid Attenuates Central Nervous System Disease in Mucopolysaccharidosis Type II MiceChristian Hinderer, Nathan Katz, Jean-Pierre Louboutin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 27, 2005
No evidence for tumorigenesis of AAV vectors in a large-scale study in micePeter Bell, Lili Wang, Corinna Lebherz, et al.
Stem Cell Reports|September 23, 2014
Professional regulation: a potentially valuable tool in responding to "stem cell tourism"Amy Zarzeczny, Timothy Caulfield, Ubaka Ogbogu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 29, 2009
Systematic evaluation of AAV vectors for liver directed gene transfer in murine modelsLili Wang, Huan Wang, Peter Bell, et al.
Human Gene Therapy|May 16, 2009
Adeno-associated virus-mediated gene transfer to nonhuman primate liver can elicit destructive transgene-specific T cell responsesGuangping Gao, Qiang Wang, Roberto Calcedo, et al.
Human Gene Therapy. Clinical Development|January 30, 2019
A Gene Therapy Approach to Improve Copper Metabolism and Prevent Liver Damage in a Mouse Model of Wilson DiseaseJenny A Greig, Jayme M L Nordin, Melanie K Smith, et al.
Molecular Therapy. Methods & Clinical Development|August 17, 2018
Determining the Minimally Effective Dose of a Clinical Candidate AAV Vector in a Mouse Model of Crigler-Najjar SyndromeJenny A Greig, Jayme M L Nordin, Christine Draper, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 2, 2019
The GPI-Linked Protein LY6A Drives AAV-PHP.B Transport across the Blood-Brain BarrierJuliette Hordeaux, Yuan Yuan, Peter M Clark, et al.
Nature Biotechnology|February 2, 2016
A dual AAV system enables the Cas9-mediated correction of a metabolic liver disease in newborn miceYang Yang, Lili Wang, Peter Bell, et al.
Pageof 11

Showing results (61-70 of 105) with videos related to

Sort By:
Pageof 11
Human Gene Therapy|April 25, 2019
Safe and Sustained Expression of Human Iduronidase After Intrathecal Administration of Adeno-Associated Virus Serotype 9 in Infant Rhesus MonkeysJuliette Hordeaux, Christian Hinderer, Elizabeth L Buza, et al.
Human Gene Therapy|August 12, 2016
Delivery of an Adeno-Associated Virus Vector into Cerebrospinal Fluid Attenuates Central Nervous System Disease in Mucopolysaccharidosis Type II MiceChristian Hinderer, Nathan Katz, Jean-Pierre Louboutin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 27, 2005
No evidence for tumorigenesis of AAV vectors in a large-scale study in micePeter Bell, Lili Wang, Corinna Lebherz, et al.
Stem Cell Reports|September 23, 2014
Professional regulation: a potentially valuable tool in responding to "stem cell tourism"Amy Zarzeczny, Timothy Caulfield, Ubaka Ogbogu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 29, 2009
Systematic evaluation of AAV vectors for liver directed gene transfer in murine modelsLili Wang, Huan Wang, Peter Bell, et al.
Human Gene Therapy|May 16, 2009
Adeno-associated virus-mediated gene transfer to nonhuman primate liver can elicit destructive transgene-specific T cell responsesGuangping Gao, Qiang Wang, Roberto Calcedo, et al.
Human Gene Therapy. Clinical Development|January 30, 2019
A Gene Therapy Approach to Improve Copper Metabolism and Prevent Liver Damage in a Mouse Model of Wilson DiseaseJenny A Greig, Jayme M L Nordin, Melanie K Smith, et al.
Molecular Therapy. Methods & Clinical Development|August 17, 2018
Determining the Minimally Effective Dose of a Clinical Candidate AAV Vector in a Mouse Model of Crigler-Najjar SyndromeJenny A Greig, Jayme M L Nordin, Christine Draper, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 2, 2019
The GPI-Linked Protein LY6A Drives AAV-PHP.B Transport across the Blood-Brain BarrierJuliette Hordeaux, Yuan Yuan, Peter M Clark, et al.
Nature Biotechnology|February 2, 2016
A dual AAV system enables the Cas9-mediated correction of a metabolic liver disease in newborn miceYang Yang, Lili Wang, Peter Bell, et al.
Pageof 11